A detailed history of Birchview Capital, LP transactions in Xencor Inc stock. As of the latest transaction made, Birchview Capital, LP holds 26,000 shares of XNCR stock, worth $341,380. This represents 0.51% of its overall portfolio holdings.

Number of Shares
26,000
Previous 12,300 111.38%
Holding current value
$341,380
Previous $247,000 141.7%
% of portfolio
0.51%
Previous 0.23%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$19.43 - $26.84 $266,191 - $367,708
13,700 Added 111.38%
26,000 $597,000
Q3 2017

Nov 02, 2017

BUY
$19.61 - $23.35 $241,203 - $287,205
12,300
12,300 $282,000

Others Institutions Holding XNCR

About Xencor Inc


  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $784M
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track Birchview Capital, LP Portfolio

Follow Birchview Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Birchview Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Birchview Capital, LP with notifications on news.